Friuli-Venezia Giulia

Friuli-Venezia Giulia

Authors

  • Roberto Gasparini Dipartimento di Scienze della Salute, Università di Genova
  • Donatella Panatto Dipartimento di Scienze della Salute, Università di Genova
  • Bruna Dirodi Direzione Access to Medicine, GlaxoSmithKline, Verona
  • Rosa Prato Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi di Foggia
  • Gianni Amunni Dipartimento di Ginecologia, Perinatologia e Riproduzione Umana, Università di Firenze
  • Valter Turello Dipartimento di Prevenzione U.O. Igiene e Sanità Pubblica, Azienda USL 3 Genova
  • Luigi Sudano Assessorato Sanità, Salute e Politiche Sociali, Servizio Igiene, Sanità Pubblica, Veterinaria e degli Ambienti di lavoro
  • Paolo Cristoforoni Dipartimento di Oncologia Ginecologica, Istituto Nazionale per la Ricerca sul Cancro, Genova
  • Sara Boccalini Dipartimento di Sanità Pubblica, Università di Firenze
  • Paolo Bonanni Dipartimento di Sanità Pubblica, Università di Firenze

DOI:

https://doi.org/10.7175/fe.v13i2S.456

Keywords:

HPV, Vaccination strategy, Screening, Friuli-Venezia Giulia, Cost-effectiveness analysis

Abstract

In Friuli-Venezia Giulia region 86% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The major number of cases avoided by the bivalent make it possible to fully offset the cost savings related to warts associated with the quadrivalent vaccine. Furthermore, a cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 90% coverage could prevent 8 cases of cervicocarcinoma and 3 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (11,960 €/QALY).

Downloads

Published

2012-11-20

How to Cite

Gasparini, R., Panatto, D., Dirodi, B., Prato, R., Amunni, G., Turello, V., … Bonanni, P. (2012). Friuli-Venezia Giulia. Farmeconomia. Health Economics and Therapeutic Pathways, 13(2S), 34–36. https://doi.org/10.7175/fe.v13i2S.456

Issue

Vol. 13 No. 2S (2012)

Section

Supplement

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>